Target intelligence / Profile preview

Apoptotic chromatin condensation inducer 1 (ACIN1)

Target
ACIN1
Molecular classification
Nuclear protein, RNA-binding protein, Spliceosome-associated protein, Member of the apoptosis and splicing–associated (ASAP) complex
01

Overview

Apoptotic chromatin condensation inducer 1 (ACIN1) encodes the nuclear protein Acinus, a multifunctional factor initially discovered for its involvement in apoptosis, primarily inducing chromatin condensation after activation by caspase-3, without direct DNA fragmentation[1][3][5]. Acinus is also an essential regulator of alternative splicing, acting within spliceosome-associated multiprotein complexes such as the exon junction complex (EJC) and the ASAP complex, which integrate cell death signals with gene expression programs[1][2][3]. Loss of ACIN1 is embryonic lethal, underscoring its developmental importance; tissue-specific knockout studies demonstrate effects on muscle regeneration and splicing of muscle-related genes[2]. Post-translational modifications (phosphorylation by Akt and SRPK2) influence its stability and apoptotic function, especially in cancer cell contexts[1]. While ACIN1 plays dual roles in cell death and RNA processing, there is currently no evidence that it is a direct therapeutic target or clinical biomarker[1][2][3][5].

Other names
AcinusApoptotic chromatin condensation inducer in the nucleusKIAA0670fSAP152 (functional spliceosome-associated protein 152)ACINUSACNApoptotic chromatin condensation inducer 1
02

Mechanism of action

Not applicable. Drugs do not directly target ACIN1.

03

Biological functions

Chromatin condensation during apoptosisComponent of multiprotein exon junction complexes (EJC)Regulation of alternative splicing and mRNA metabolismInduction of DNA fragmentation in apoptosisModulation of cyclin A1 expression and cell cycle progression
04

Disease associations

Developmental disorders (e.g., embryonic lethality in knockout models)Cancer (modulates apoptotic pathways and cell cycle regulators)Cardiovascular syphilis (reported association)Muscle diseases (affects gene splicing linked to muscle pathology)

Beyond the preview

Go deeper on Apoptotic chromatin condensation inducer 1 (ACIN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptotic chromatin condensation inducer 1 (ACIN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call